Showing results (1871-1880 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|January 29, 2009
Assessing residual confounding of the association between antipsychotic medications and risk of death using survey dataSebastian Schneeweiss, Soko Setoguchi, M Alan Brookhart, et al.CNS Drugs|March 27, 2007
When should clozapine be initiated in schizophrenia?: Some arguments for and against earlier use of clozapineRobert KerwinCNS Drugs|February 8, 2007
Lack of insight in schizophrenia: impact on treatment adherencePeter F Buckley, Donna A Wirshing, Prameet Bhushan, et al.CNS Drugs|December 28, 2006
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraineDavid W Dodick, Giorgio Sandrini, Paul WilliamsCNS Drugs|December 10, 2008
Ropinirole prolonged release: in advanced Parkinson's diseaseJuliane Weber, Gillian M KeatingCNS Drugs|June 26, 2009
Pharmacotherapy for cannabis dependence: how close are we?Ryan Vandrey, Margaret HaneyCNS Drugs|June 26, 2009
Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersGiulia Curia, Giuseppe Biagini, Emilio Perucca, et al.CNS Drugs|June 26, 2009
Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorderCarlos A Zarate, Husseini K ManjiCNS Drugs|June 26, 2009
Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatmentAlex D H Brown, David A Barton, Gavin W LambertCNS Drugs|June 26, 2009
Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanismsFabio Fumagalli, Angelisa Frasca, Giorgio Racagni, et al.Pageof 211